CareDx EPS - Earnings per Share 2013-2025 | CDNA
CareDx eps - earnings per share from 2013 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| CareDx Annual EPS | |
|---|---|
| 2024 | $0.93 |
| 2023 | $-3.54 |
| 2022 | $-1.44 |
| 2021 | $-0.59 |
| 2020 | $-0.40 |
| 2019 | $-0.52 |
| 2018 | $-1.31 |
| 2017 | $-2.38 |
| 2016 | $-2.39 |
| 2015 | $-1.16 |
| 2014 | $0.10 |
| 2013 | $-3.50 |
| 2012 | $-5.01 |
| CareDx Quarterly EPS | |
|---|---|
| 2025-06-30 | $-0.16 |
| 2025-03-31 | $-0.19 |
| 2024-12-31 | $1.54 |
| 2024-09-30 | $-0.14 |
| 2024-06-30 | $-0.09 |
| 2024-03-31 | $-0.38 |
| 2023-12-31 | $-2.21 |
| 2023-09-30 | $-0.43 |
| 2023-06-30 | $-0.46 |
| 2023-03-31 | $-0.44 |
| 2022-12-31 | $-0.34 |
| 2022-09-30 | $-0.32 |
| 2022-06-30 | $-0.41 |
| 2022-03-31 | $-0.37 |
| 2021-12-31 | $-0.31 |
| 2021-09-30 | $-0.23 |
| 2021-06-30 | $-0.04 |
| 2021-03-31 | $-0.01 |
| 2020-12-31 | $-0.05 |
| 2020-09-30 | $-0.06 |
| 2020-06-30 | $-0.15 |
| 2020-03-31 | $-0.14 |
| 2019-12-31 | $-0.11 |
| 2019-09-30 | $-0.04 |
| 2019-06-30 | $-0.19 |
| 2019-03-31 | $-0.18 |
| 2018-12-31 | $-0.07 |
| 2018-09-30 | $-0.54 |
| 2018-06-30 | $-0.40 |
| 2018-03-31 | $-0.30 |
| 2017-12-31 | $-1.30 |
| 2017-09-30 | $-0.63 |
| 2017-06-30 | $-0.19 |
| 2017-03-31 | $-0.26 |
| 2016-12-31 | $-0.55 |
| 2016-09-30 | $-0.26 |
| 2016-06-30 | $-0.77 |
| 2016-03-31 | $-0.81 |
| 2015-12-31 | $-0.41 |
| 2015-09-30 | $-0.29 |
| 2015-06-30 | $-0.27 |
| 2015-03-31 | $-0.19 |
| 2014-12-31 | $1.14 |
| 2014-09-30 | $0.12 |
| 2014-06-30 | $0.13 |
| 2014-03-31 | $-1.29 |
| 2013-12-31 | $-0.56 |
| 2013-09-30 | $-0.82 |
| 2013-06-30 | $-0.79 |
| 2013-03-31 | $-1.33 |
| 2012-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.690B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.660B | 28.13 |
| CVS Health (CVS) | United States | $90.432B | 11.25 |
| Elevance Health (ELV) | United States | $71.280B | 9.59 |
| Cencora (COR) | United States | $56.729B | 18.89 |
| DiDi Global (DIDIY) | China | $27.580B | 29.30 |
| Labcorp Holdings (LH) | United States | $23.117B | 18.37 |
| Natera (NTRA) | United States | $22.728B | 0.00 |
| BioMerieux (BMXMF) | France | $17.547B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.699B | 0.00 |
| ICON (ICLR) | Ireland | $14.200B | 13.66 |
| Medpace Holdings (MEDP) | United States | $13.025B | 34.47 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.753B | 13.16 |
| Viatris (VTRS) | United States | $12.417B | 4.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $11.052B | 0.00 |
| Revvity (RVTY) | United States | $10.928B | 19.25 |
| Avantor (AVTR) | United States | $9.047B | 13.27 |
| Sonic Healthcare (SKHHY) | Australia | $8.007B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.965B | 15.11 |
| HealthEquity (HQY) | United States | $7.767B | 34.02 |
| Bausch + Lomb (BLCO) | Canada | $5.289B | 35.57 |
| Sotera Health (SHC) | United States | $4.667B | 26.08 |
| BrightSpring Health Services (BTSG) | United States | $4.406B | 33.61 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| KindlyMD (NAKA) | United States | $3.810B | 0.00 |
| GeneDx Holdings (WGS) | United States | $3.696B | 84.65 |
| Alignment Healthcare (ALHC) | United States | $3.137B | 0.00 |
| Concentras Parent (CON) | United States | $3.031B | 19.23 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| Organon (OGN) | United States | $2.451B | 2.67 |
| Premier (PINC) | United States | $2.070B | 19.19 |
| Progyny (PGNY) | United States | $2.023B | 42.78 |
| Ardent Health (ARDT) | United States | $1.858B | 7.17 |
| PACS (PACS) | United States | $1.836B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.584B | 26.82 |
| Pediatrix Medical (MD) | United States | $1.481B | 9.89 |
| Teladoc Health (TDOC) | United States | $1.357B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.264B | 0.00 | |
| Omada Health (OMDA) | $1.227B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.841B | 4.92 |
| AMN Healthcare Services Inc (AMN) | United States | $0.795B | 9.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.641B | 110.00 |
| Performant Healthcare (PHLT) | United States | $0.599B | 0.00 |
| Agilon Health (AGL) | United States | $0.551B | 0.00 |
| Nutex Health (NUTX) | United States | $0.513B | 7.77 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.457B | 6.87 |
| SBC Medicals (SBC) | United States | $0.444B | 9.75 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.415B | 27.30 |
| So-Young (SY) | China | $0.411B | 0.00 |
| Oncology Institute (TOI) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.280B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.194B | 0.00 |
| DocGo (DCGO) | United States | $0.168B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.145B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| ModivCare (MODV) | United States | $0.015B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |